Literature DB >> 11953460

Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum.

Mark G Devlin1, Arthur Christopoulos.   

Abstract

Cross-talk between cannabinoid CB1 and serotonin 5-HT receptors in rat cerebellar membranes was investigated using radioligand binding. In competition against the CB1 antagonist, [3 H]SR141716A, the agonist, WIN 55,212-2 yielded a biphasic isotherm. The majority of binding was to a high-affinity state that was significantly reduced by the GTP analogue, Gpp(NH)p. Interestingly, 5-HT enhanced the high-affinity binding constant of WIN 55,212-2 while attenuating the proportion of high-affinity binding. 5-HT also significantly reduced the proportion of high-affinity binding of the cannabinoid agonist, HU 210, but had no effect on the agonist, CP 55,940. The effect of 5-HT on WIN 55,212-2 binding was inhibited by the 5-HT2 receptor antagonist ritanserin as well as Gpp(NH)p, suggesting a dependence on the 5-HT2 receptor and on G protein-receptor interactions, respectively. Subsequent [3 H]WIN 55,212-2 dissociation kinetic experiments revealed that 5-HT promoted a slower-dissociating species of radiolabelled agonist-receptor complex. Our findings support a membrane-delimited cross-talk between two G protein-coupled receptors that are co-localized in certain cells of the central nervous system. Intriguingly, the cannabinoid agonist dependence of the 5-HT modulatory effect suggests that agonist-specific conformations of the CB1 receptor may also be important in determining the extent of this cross-talk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953460     DOI: 10.1046/j.0022-3042.2002.00797.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  [Cannabinoids--signal transduction and mode of action].

Authors:  R Rukwied; B Gauter; M Schley; C Konrad
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

2.  Agonistic properties of cannabidiol at 5-HT1a receptors.

Authors:  Ethan B Russo; Andrea Burnett; Brian Hall; Keith K Parker
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

3.  Chronic Delta9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex.

Authors:  Onintza Sagredo; José A Ramos; Javier Fernández-Ruiz; María L López Rodríguez; Rosario de Miguel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-12-30       Impact factor: 3.000

Review 4.  Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+.

Authors:  Tim D Werry; Graeme F Wilkinson; Gary B Willars
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

5.  Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.

Authors:  Matthew N Hill; Wing-Sze Vanessa Ho; Cecilia J Hillard; Boris B Gorzalka
Journal:  J Neural Transm (Vienna)       Date:  2008-10-31       Impact factor: 3.575

6.  Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors.

Authors:  Mark Bauer; Andrea Chicca; Marco Tamborrini; David Eisen; Raissa Lerner; Beat Lutz; Oliver Poetz; Gerd Pluschke; Jürg Gertsch
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

7.  Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions.

Authors:  Shirley A Hesketh; Adrian K Brennan; David S Jessop; David P Finn
Journal:  Psychopharmacology (Berl)       Date:  2007-12-15       Impact factor: 4.530

Review 8.  Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders.

Authors:  Malvika Kaul; Phyllis C Zee; Ashima S Sahni
Journal:  Neurotherapeutics       Date:  2021-02-12       Impact factor: 7.620

Review 9.  Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine.

Authors:  Gábor Nagy-Grócz; Ferenc Zádor; Szabolcs Dvorácskó; Zsuzsanna Bohár; Sándor Benyhe; Csaba Tömböly; Árpád Párdutz; László Vécsei
Journal:  Int J Mol Sci       Date:  2017-07-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.